Latest news
Loading news…
Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.
Adverum Biotechnologies was acquired by Eli Lilly in 2025.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
179
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Menlo Park, California, United States
Key People at Adverum Biotechnologies
Chief Science and Technology Officer, SVP Pharmaceutical Development
Chief Financial Officer
CSO
Chief Development Officer
Founder & Director
Director
179
professional contacts at Adverum Biotechnologies
Contact execs at Adverum Biotechnologies →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Adverum Biotechnologies
Loading news…
FAQs about Adverum Biotechnologies
People who checked this page also checked these
Browse the full Acquirezy directory.